Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)
FASHE
Study of Quality of Life After Aneurysmal Subarachnoid Hemorrhage in Patients Aged 70 Years or Older.
1 other identifier
observational
353
1 country
2
Brief Summary
In all the Western populations, the annual incidence of subarachnoid hemorrhage (SAH) increase with age. In patients older than 70 years, the occurrence of SAH exposes them to high risk of morbidity and a poor quality of life. In this age bracket, the single randomized which compared endovascular coiling to microsurgical clipping (ISAT Study) showed that the relative risk of morbidity increased after coiling. Moreover, some prospectives studies about endovascular coiling described favorable outcome in 48% to 63% of patients, complete occlusion in 51% to 69% and a procedural complication rate in 13% to 19%. From prospectives series, the proportion of favorable outcome after microsurgical clipping was estimated around 66% but the procedural complications are few reported. The outcome for patients treated conservatively was catastrophic. Lastly, the hydrocephalus in this age class is common, occurring in 55% of patients. The study hypothesis is that, in this age class, no difference exists between the 2 obliteration procedures. An accurate evaluation of result in term of functional disability, quality of life and prognosis predictive factors seems a judicious question.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2008
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedSeptember 3, 2014
September 1, 2014
5.3 years
June 3, 2008
September 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Rankin Scale score
12 months
Secondary Outcomes (5)
Min Mental State Examination
12 months
Quality of LIfe, QLQ C30 questionnaire from EORTC
12 months
Self-maintaining and instrumental activities of daily living, ADL and IADL score
12 months
Hydrocephalus and risk factors
12 months
Causes of morbidity and mortality
12 months
Study Arms (5)
Randomized microsurgical
After randomization, this group was constituted of patients treated by microsurgical clipping.
Randomized endovascular
After randomization, this group was constituted of patients treated by endovascular coiling.
Prospective observational microsurgical
The randomization was ethically unsuitable because of the aneurysm predisposed to the microsurgical clipping after discussion into the neurovascular interdisciplinary team.
Prospective observational endovascular
The randomization was ethically unsuitable because of the aneurysm morphology predisposed to the endovascular coiling after discussion into the neurovascular interdisciplinary team.
Prospective observational conservative
This group was constituted of patients whom no curative treatment of the aneurysm sac could not be proposed.
Eligibility Criteria
Primary cara clinic in differents countries of France
You may qualify if:
- years old and more
- Subarachnoid hemorrhage in grade I-IV of WFNS scale
- Ruptured cerebral aneurysm diagnosed on multislice computed tomography angiography or cerebral angiography
- treatment of subarachnoid hemorrhage
You may not qualify if:
- Patients in grade V of WFNS scale
- Subarachnoid hemorrhage without cerebral aneurysm
- Patients with cerebral dementia, neurologic or psychiatric antecedents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
PROUST
Rouen, 76031, France
Rouen University Hospital
Rouen, 76031, France
Related Publications (2)
Proust F, Gerardin E, Derrey S, Lesveque S, Ramos S, Langlois O, Tollard E, Benichou J, Chassagne P, Clavier E, Freger P. Interdisciplinary treatment of ruptured cerebral aneurysms in elderly patients. J Neurosurg. 2010 Jun;112(6):1200-7. doi: 10.3171/2009.10.JNS08754.
PMID: 19961311BACKGROUNDProust F, Bracard S, Thines L, Leclerc X, Penchet G, Berge J, Vignes JR, Irthum B, Gabrillargues J, Chazal J, Bataille B, Drouinau J, Mourier K, Ricolfi F, Gay E, Bessou P, Lonjon M, Sedat J, David P, Lajaunias P, Morandi X, Gauvrit JY, Pelissou I, Turjman F, Roche PH, Dufour H, Levrier O, Emery E, Courtheoux P, Laguarrigue J, Cognard C, Civit T, Lejeune JP. [Aneurismal subarachnoid hemorrhage in the elderly subject. Should this patient participate in a randomized clinical trial?]. Neurochirurgie. 2010 Feb;56(1):67-72. doi: 10.1016/j.neuchi.2009.11.002. Epub 2010 Jan 8. No abstract available. French.
PMID: 20060549BACKGROUND
Biospecimen
2 randomized arms (clipping and coiling) and 3 prospective observational arms (clipping, coiling, conservative) For the randomized arms, we anticipated 20 patients in each arm.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François PROUST, M.D., Ph.D.
University Hospital, Rouen
- PRINCIPAL INVESTIGATOR
Serge BRACARD, M.D., Ph.D.
Central Hospital, Nancy, France
- STUDY DIRECTOR
Guillaume PENCHET, M.D.
University Hospital, Bordeaux
- STUDY DIRECTOR
Evelyne EMERY, M.D.
University Hospital, Caen
- STUDY DIRECTOR
Bernard IRTHUM, M.D.
Clermont University Hospital
- STUDY DIRECTOR
Klaus MOURIER, M.D.
Centre Hospitalier Universitaire Dijon
- STUDY DIRECTOR
Emmanuel GAY, M.D.
University Hospital, Grenoble
- STUDY DIRECTOR
Jean-Paul LEJEUNE, M.D.
Lille University Hospital
- STUDY DIRECTOR
Isabelle PELISSOU, M.D.
Hospices Civils de Lyon
- STUDY DIRECTOR
Pierre Hughes ROCHE, M.D.
University Hospital, Marseille
- STUDY DIRECTOR
Thierry CIVIT, M.D.
Central Hospital, Nancy, France
- STUDY DIRECTOR
Michel LONJON, M.D.
Nice University Hospital
- STUDY DIRECTOR
Philippe DAVID, M.D.
Paris University Hospital
- STUDY DIRECTOR
Benoit BATAILLE, M.D.
Poitiers University Hospital
- STUDY DIRECTOR
Xavier MORANDI, M.D.
Rennes University Hospital
- STUDY DIRECTOR
Jacques LAGUARRIGUE, M.D.
University Hospital, Toulouse
- STUDY DIRECTOR
Romain BILLON-GRAND, M.D.
Besançon University Hospital
- STUDY DIRECTOR
Damien BRESSON, M.D.
Paris University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2008
First Posted
June 6, 2008
Study Start
October 1, 2008
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
September 3, 2014
Record last verified: 2014-09